Table 1

Baseline characteristics

Variable Crohn's disease (n=383) Ulcerative colitis (n=434) Normal controls (n=635) p Value
Male117 (31%)160 (37%)324 (51%)<0.0011-151
Female266 (69%)274 (63%)311 (50%)
Age (median, range)39 (8–82)39 (11–86)43 (19–93)<0.0011-152
Smoking<0.0011-151
 Never smoked106 (28%)209 (48%)252 (40%)
 Current smoker188 (49%)72 (17%)215 (34%)
 Previous smoker87 (23%)151 (35%)167 (26%)
Use of corticosteroids1-153 324 (85%)386 (89%)34 (5%)<0.0011-151
Age at first use of corticosteroids (median, range)28 (3–76)30 (10–78)35 (11–75)0.0281-152
Duration of corticosteroid use1.001-151
 <1 year151 (47%)179 (47%)15 (47%)
 ⩾1 year173 (53%)205 (53%)17 (53%)
Ever diagnosed with osteoporosis14 (4%)9 (2%)5 (1%)0.0071-151
Family history of osteoporosis1-154 22 (6%)23 (5%)22 (4%)0.371-151
Family history of fractures1-154 166 (38%)169 (39%)225 (40%)0.871-151
Use of oral contraceptives1-150 221 (84%)220 (80%)227 (74%)0.011-151
Age at first use of oral contraceptives (median, range)1-150 18 (12–37)18 (15–42)19 (13–40)0.0021-152
Duration of oral contraceptive use1-150 0.0061-151
 <5 years71 (32%)88 (40%)105 (47%)
 ⩾5 years150 (68%)132 (60%)119 (53%)
Premenopausal1-150 Postmenopausal1-150 206 (77%) 60 (23%)214 (78%) 59 (22%)226 (73%) 84 (27%)0.251-151
Age at menopause in years (median, range)1-150 47 (34–54)50 (30–55)48 (30–58)0.0031-152
Use of HRT after menopause1-150 37 (63%)29 (49%)31 (36%)0.0081-151
Age at first HRT use in years (median, range)1-150 48.5 (37–60)49 (35–56)48 (40–60)0.921-151
Duration of HRT use1-150 0.951-151
 <5 years20 (54%)15 (52%)15 (50%)
 >5 years17 (46%)14 (48%)15 (50%)
  • 1-150 Only female respondents.

  • 1-151 χ2 for contingency tables (p).

  • 1-152 Kruskal-Wallis test (2p).

  • 1-153 Any type of corticosteroids (oral, enemas, inhaled, topical, etc).

  • 1-154 A family history means occurrence of any fracture among parents or siblings.

  • Owing to missing values, sums may not add up.

  • HRT, hormone replacement therapy.